Cargando…

S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandarino, Angelo, Thiyagarajan, Swetha, Martins, Allana C. F., Gomes, Roberto da Silva, Vetter, Stefan W., Leclerc, Estelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452588/
https://www.ncbi.nlm.nih.gov/pubmed/37627239
http://dx.doi.org/10.3390/biom13081175
_version_ 1785095707126923264
author Mandarino, Angelo
Thiyagarajan, Swetha
Martins, Allana C. F.
Gomes, Roberto da Silva
Vetter, Stefan W.
Leclerc, Estelle
author_facet Mandarino, Angelo
Thiyagarajan, Swetha
Martins, Allana C. F.
Gomes, Roberto da Silva
Vetter, Stefan W.
Leclerc, Estelle
author_sort Mandarino, Angelo
collection PubMed
description Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson’s correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
format Online
Article
Text
id pubmed-10452588
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104525882023-08-26 S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors Mandarino, Angelo Thiyagarajan, Swetha Martins, Allana C. F. Gomes, Roberto da Silva Vetter, Stefan W. Leclerc, Estelle Biomolecules Article Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson’s correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles. MDPI 2023-07-28 /pmc/articles/PMC10452588/ /pubmed/37627239 http://dx.doi.org/10.3390/biom13081175 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mandarino, Angelo
Thiyagarajan, Swetha
Martins, Allana C. F.
Gomes, Roberto da Silva
Vetter, Stefan W.
Leclerc, Estelle
S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title_full S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title_fullStr S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title_full_unstemmed S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title_short S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
title_sort s100s and hmgb1 crosstalk in pancreatic cancer tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452588/
https://www.ncbi.nlm.nih.gov/pubmed/37627239
http://dx.doi.org/10.3390/biom13081175
work_keys_str_mv AT mandarinoangelo s100sandhmgb1crosstalkinpancreaticcancertumors
AT thiyagarajanswetha s100sandhmgb1crosstalkinpancreaticcancertumors
AT martinsallanacf s100sandhmgb1crosstalkinpancreaticcancertumors
AT gomesrobertodasilva s100sandhmgb1crosstalkinpancreaticcancertumors
AT vetterstefanw s100sandhmgb1crosstalkinpancreaticcancertumors
AT leclercestelle s100sandhmgb1crosstalkinpancreaticcancertumors